INS and hydrops fetalis: The estimated 5-year HF rate in the insulin group differed across the 3 comparisons due to differences in the populations’ distributions of baseline characteristics and the corresponding differences in HF risk, as well as the exclusion of some patients with an extreme probability of receiving a particular treatment due to their inability to be matched with the other treatment group.